The Global Veterinary Infusion Pump Market, by Product Type (Syringe Infusion Pump and Large-Volume Infusion Pump), by End User (Veterinary Hospitals and Veterinary Clinics) was valued US$ 76.89 million in 2017 and is projected to exhibit a CAGR of 5.6% over the forecast period (2017 - 2025) as highlighted in a new report published by Coherent Market Insights. Technological advancement by market players coupled with rising awareness regarding pet care are the major factors driving growth of the global veterinary infusion pump market over the forecast period.
Veterinary infusion pump delivers controlled amount of fluid and medications into the bloodstream over a period of time. Increasing prevalence of cancer along with rise in relapsed cancer rates indicates a need to adopt approved novel immunotherapies and targeted therapies, which are proved to be highly effective for the treatment of cancers in pets, thus, augmenting the veterinary infusion pump market growth. Hence, the manufacturers are involved in the launches of innovative products in the market. For instance, Vet Pro SP 3000 by Caesarea Medical Electronics for vet can provide accurate small dose and linear infusions. Furthermore, the device has a special feature of drug volume detection, which makes it easy and quick to set up an infusion for any animal.
Furthermore, increasing number of manufactures in the market offering veterinary pumps are driving manufacturers to develop innovative devices. For instance, BodyGuard 121 Twins for vet by Caesarea Medical Electronics allows user to set up fast high volume rapid infusions by mixing two different infusion solutions for an animal or by infusing to two different animals from one device.
Moreover, the rise in hospital admission rate due to obesity is expected to propel demand for veterinary infusion pumps market. According to the Association for Pet Obesity Prevention (APOP), in U.S. 54 percent dogs and 59 percent of cats were overweight or obese in 2016, the number of which increased to 56 percent dogs and 60 percent cats in 2017.
Furthermore, manufacturers are focused on the development of infusion pumps especially for veterinary clinics, which is expected to boost the demand for veterinary infusion pump from clinics across the globe. For instance, Heska developed HESKA VET/IV 2.2 Infusion Pump for clinical use, whose calibration is available for Abbott Series A and B, Baxter ACT 5435s Henry Schein UniverSet. Its low weight (2.6 pounds) and compact structure makes it easy to carry and requires less space.
Key takeaways of the Veterinary Infusion Pump Market:
- The global veterinary infusion pump market is expected to expand at a CAGR of 5.6% during the forecast period (2017 – 2025), owing to increasing prevalence of disability among geriatric population.
- Large Volume Infusion Pump segment holds a major market share in product type, due to technical advancements and innovations by the manufacturers.
- Furthermore, the manufacturers are involved in innovation with the products such as HESKA VET/IV 2.2, and Vet Pro SP 3000 to make them more user friendly and cost effective. The cost effective nature of this product is expected to boost market revenue over the forecast period.
- Some of the major players operating in global veterinary infusion pump market are B. Braun Melsungen AG, Heska Corporation, Q Core Medical Ltd., Burtons Medical Equipment Ltd., DRE Medical, Inc., Grady Medical, Promed Group Co., Ltd., and SAI Infusion Technologies.
About CMI
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
No comments:
Post a Comment